Company

DIAGNOSTIC BIOCHIPS IS REVOLUTIONIZING THE FUTURE OF IMPLANTABLE NEURAL SENSORS AND REAL TIME CHEMOSENSING.

Our Team

Our team has been working tirelessly in research and development for decades, leading the way in generating new bioelectronics therapies for humans. Our goal is to be the recognized benchmark for multi-parameter in vivo sensing, using demonstrably superior technology for monitoring of the rapidly-changing chemical and biophysical environment of the body. 

DBC TEAM

BRIAN JAMIESON

Founder and CTO

Brian Jamieson founded Diagnostic Biochips (DBC) in 2013 to drive groundbreaking advances in understanding the brain through the development of advanced neural interfacing systems. His 20 years of engineering expertise in hardware-oriented R&D includes applying micro- and nano-technology to challenging problems in medicine, biology and science. Prior to DBC, Brian was President of SBM (Scientific & Biomedical Microsystems), an engineering services and R&D firm, which he founded in 2006. Before SBM, Brian was a Micro-Electro-Mechanical-Systems (MEMS) Group Leader for the NASA Goddard Space Flight Center, where he worked on instrument miniaturization for unmanned space missions and initiated a lab-on-a-chip (LOAC) program to develop micro-fluidic platforms for space-based assays and astronaut health monitoring.

Brian currently serves on the Scientific Advisory Board of the Maryland Science Center, as an industry advisor to the Georgetown Graduate Program in Physics, and on review panels for NASA, the NIH, and the International Technology Roadmap for Semiconductors. He earned both a Ph.D. in Biomedical Engineering and an M.S. in Electrical Engineering from the University of Michigan, and completed his B.S. in Physics at Yale University. Brian earned a silver medal at the 1996 Olympics in rowing and is a Board member and past president of CRAB (Chesapeake Region Accessible Boating), an organization that teaches people with disabilities how to sail.

GREG ALDEN

President and CEO

Greg Alden’s 25-year career has been built on optimizing data communications to solve big problems, from the early broadband internet in the early 90’s, the introduction of data to mobile communications, and most recently within the human brain. Greg joined Diagnostic Biochips (DBC) in mid 2018 as an advisor and became President and CEO in early 2019, bringing a wealth of business expertise and with his own diagnosis of Parkinson’s disease in 2009, a personal drive to pioneer next-generation medical devices and therapies for neurological diseases and disorders. He is responsible for leading DBC’s mission to create a common approach to capture and leverage brain data in a standardized, highly repeatable and measurable way.

Previously, Greg served as CEO and Founder of Enclave Data. Before that, he was CEO and Founder of RIFT, a leader in network automation, as well as founding member of Movik Networks. From 1992 to 2008, Greg was instrumental in building two companies that were ultimately acquired by Cisco: Compatible Systems Corporation, followed by Starent Networks. Between these two endeavors, Greg also spent seven years at Cisco holding several senior positions including a role as a founder of Cisco’s U.S. Mobile Operations which his team grew to over $1B in revenue in just over two years. Greg is the co-author of several patents in the areas of networking and virtualization, and spends his free time with his five kids or participating in triathlons and offshore sailing.

FAN WU

Vice President, Product Development

Fan Wu is a biomedical and electrical engineer with more than 10 years of experience in design, micro-fabrication and testing of micro-electromechanical systems (MEMS) for biomedical applications. As VP of Product Development at Diagnostic Biochips, he is focused on innovating the field of advanced implantable sensors. Fan has published 15 scientific journals and holds three patents related to his doctoral thesis, which was focused on designing implantable devices with integrated nano-photonics and circuits to map brain functions with unprecedented spatiotemporal resolution.

Throughout his career, Fan has achieved recognition in the form of the National Science Foundation (NSF) Graduate Student Fellowship award, Best Oral Presentation award at the 17th International Conference on Solid-State Sensors, Actuators and Microsystems, “Highlight of the year” in the Journal of Neural Engineering in 2013, and a cover-page article in Neuron, vol.88, 2015. While working as a post-doctoral researcher at the University of Michigan, Fan was awarded by NSF under the Innovation Corps program to develop a business plan to commercialize his research. Fan earned his Ph.D. and M.S. in Electrical Engineering from the University of Michigan, and his B.S. in Biomedical Engineering from the University of Wisconsin. He does not waste a single day off at home, and always finds new places in the world to travel each year for hiking, scuba diving and skiing.

Scientific Advisory Board

KEVIN PLAXCO, PHD

Professor & Vice Chair, Department of Chemistry and Biochemistry, University of California at Santa Barbara

BARBARA SLUSHER, PHD

Director, Brain Science Institute NeuroTranslation Drug Discovery Program, Johns Hopkins University

X. TRACY CUI, PHD

Associate Professor, Department of Bioengineering, University of Pittsburgh

WARREN GRILL, PHD

Professor, Department of Biomedical Enginering, Duke UniversityŸ

GET IN TOUCH

If you would like to learn more about how Diagnostic Biochips is altering the possibilities of neural and chemical research, please feel free to contact us for more information.

Powered by